Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007;52(12):990-998.
doi: 10.1007/s10038-007-0205-7. Epub 2007 Oct 19.

Recurrent ATP1A2 mutations in Portuguese families with familial hemiplegic migraine

Affiliations

Recurrent ATP1A2 mutations in Portuguese families with familial hemiplegic migraine

Maria-José Castro et al. J Hum Genet. 2007.

Abstract

Familial hemiplegic migraine is a rare autosomal dominant subtype of migraine with aura. Three genes have been identified, all involved in ion transport. There is considerable clinical variation associated with FHM mutations. Genotype-phenotype correlation studies are needed, but are challenging mainly because the number of carriers of individual mutations is low. One exception is the recurrent T666M mutation in the FHM1 CACNA1A gene that was identified in almost one-third of FHM families and showed variable associated clinical features and severity, both within and among FHM families. Similar studies in the FHM2 ATP1A2 gene have not been performed because of the low number of carriers with individual mutations. Here we report on the recurrence of ATP1A2 mutations M731T and T376M that affect sodium-potassium pump functioning in two Portuguese FHM families. Considerably increasing the number of mutation carriers with these mutations indicated a clear genotype-phenotype correlation: both mutations are associated with pure FHM. In addition, we show that recurrent mutations for ATP1A2 are more frequent than previously thought, which has implications for genotype-phenotype correlations and genetic testing.

PubMed Disclaimer

References

    1. Lancet. 2001 Sep 8;358(9284):801-7 - PubMed
    1. Neurology. 2005 Dec 13;65(11):1826-8 - PubMed
    1. Am J Physiol. 1992 Mar;262(3 Pt 1):C743-51 - PubMed
    1. Proc Natl Acad Sci U S A. 2005 Aug 2;102(31):11106-11 - PubMed
    1. Neurology. 1999 Jul 13;53(1):38-43 - PubMed

Publication types

Substances

LinkOut - more resources